2 three-bagger stocks that could still be cheap

Roland Head highlights a stock from his own portfolio that’s he’s backing for further gains.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Many stocks look expensive after a 200% gain. But the companies I’ve chosen today still seem cheap to me, even though they’ve three-bagged over the last couple of years.

Profit from market caution

Small-cap North Sea oil producer Serica Energy (LSE: SQZ) has risen by 200% since last September. This surge followed the news that the company had agreed to use some of its cash pile to buy three mature, producing North Sea oil fields from supermajor BP.

The Bruce, Keith and Rhum (BKR) fields will add 50m barrels of oil equivalent to Serica’s reserves. They’re expected to increase the group’s net production to 21,000 barrels per day. The resulting cash flow is expected to lift the group’s profits from $10.8m in 2017 to $83.4m in 2018.

However, the share price doesn’t yet reflect these gains. Serica stock currently trades on a 2018 forecast P/E of 3. It’s clear that investors aren’t yet willing to credit the firm’s transformation.

Two risks

The first risk facing Serica is that production from its only producing field is currently stopped due to a pipeline blockage.

Output from the Erskine field was cut off in January, during cleaning operations. According to an update today, a small gap has been opened up, but service has not yet resumed. In the meantime, the group must be losing money.

A second risk is that the BP transaction isn’t expected to complete until the third quarter of 2018. Although the deal will be backdated to 1 January, the company won’t receive any cash from the BKR fields until late this year.

I don’t see either of these risks as a major concern. Serica reported net cash of $30.7m at the mid-point of last year and should be able to ride out any short-term losses. I believe the shares could double again over the next 18 months.

More of the same, please

Yesterday’s final results from mid-cap oil and gas firm Premier Oil (LSE: PMO) received a fairly positive reception from the market. The group’s stock — which I own — has tripled from the lows seen in January 2016, but continues to offer good value in my view.

I’ve recently bought more of these shares because I don’t think the 71p price reflects all of the progress that’s likely over the next 18 months.

The first area of improvement is debt reduction. Yesterday’s results showed a marginal fall in net debt to $2,724.2m in 2017. But the firm also released details of bond redemptions which lead me to think that this net debt figure could already be around $200m lower, at about $2.5bn.

Debt reduction is expected to speed up in the second half of this year, as production from the Catcher field reaches full capacity. In the meantime, I think some of the company’s undeveloped assets could attract outside interest.

Funding has already been agreed to develop the Tolmount gas field, which is targeting 540 billion cubic feet of gas resources. But Premier also has last year’s “world class” Zama oil discovery in offshore Mexico and the Sea Lion field in the Falkland Islands.

The stock currently trades on a 2018 forecast P/E of 6, reflecting its high debt burden. But as borrowings fall and progress is made with new projects, I expect the shares to rise significantly from current levels.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of Premier Oil. The Motley Fool UK has recommended BP. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why H1 results could boost the AstraZeneca share price

The AstraZeneca share price has been a success story in the past five years. With H1 results due, can it…

Read more »

Investing Articles

£17,365 in savings? Here’s how I’d use it to target a £6,700-a-month passive income

Here's how a lump sum investment could pave the way for me to make a four-figure monthly passive income in…

Read more »

Investing Articles

Down more than 10% in 6 months, Fools are backing these 5 UK stocks to reverse that – and then some! – by 2025

Some of our UK free-site writers have put forward their candidates for turnaround stocks!

Read more »

Investing Articles

Down 23%! Should I buy more CrowdStrike shares for my Stocks and Shares ISA?

Sometimes bad news can be good news for long-term investors. But is that the case for CrowdStrike in relation to…

Read more »

Investing Articles

2 UK shares near 52-week lows I’m considering snapping up

These UK shares are loitering near, or at, 52-week lows. Are these prime opportunities for our writer to boost her…

Read more »